The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Major Adverse Kidney Events in the American Indian or Alaska Native Population with Diabetes

Zemke A, Mayhand KN, Alicic RZ, Kornowske LM, Jones CR, Daratha KB, Reynolds CL, Nicholas SB, Petousis P, Shpaner L, Neumiller JJ, Norris KC, Bansal[...]

Reproductive Planning and Preconception Counseling in Kidney Disease (REPKID):A Cross-Sectional Survey

Lee G, Al Baghdadi M, Iraheta YA, Kwan L, Han CS, Nobakht N. Reproductive Planning and Preconception Counseling in Kidney Disease (REPKID):A Cross-Sectional Survey. Kidney[...]

Fabry Disease: Current Perspectives on Diagnosis and Management Strategies

Norouzi S, Ghozloujeh ZG, Lerma E, Hwang MR, Rastogi A. Fabry Disease: Current Perspectives on Diagnosis and Management Strategies. Adv Kidney Dis Health. 2026 Jan;33(1):92-102.[...]